to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
With medical device companies becoming increasingly frustrated with the U.S. Food and Drug Administration, many American companies are looking to Europe to get approval there first. Here are some tips to consider before pursuing the CE Mark.
Venture firms are approaching angel investor groups to co-invest at the growth stage of startups. Read more about the impact this could have on startup health IT companies.
Biotech companies that work with healthcare payers can get a better sense of the kinds of innovations that are most in demand. Read more about how working with payers can give innovators an edge.
In biotech research, the gathering and analysis of data takes a great deal of time. With portable legal consent, Sage Bionetworks aims to reduce data collection time for researchers so they can make their discoveries earlier.
Medical foundations play a role in helping medicine advance through their philanthropy, but sometimes even the most well-intentioned of them can lose their way. Read more about how these foundations can stay focused on their goals.
Should the U.S. Food and Drug Administration protect the public or drive innovation? One industry leader gives us his take on the future of the FDA.
Adam Lowry, co-founder of Method Products, has spent the last decade developing sustainable products that caused major disruption in the consumer goods sector. Lowry offers many of principles that guide Method's path to success and he describes the different obsessions the company keeps to deliver on its promises to customers.
The Chief Academic Officer of the Center for Integration of Medicine and Innovative Technology urges busy doctors not to ignore the ideas they have for improving medicine.
Panelists at the Partnering for Cures conference agreed that straightening out the economy here and abroad would go a long way toward making research dollars available to advance biomedical research. However, until economic conditions improve, it's hard to say how biomedical startups will fare.
This week, eMed will be providing coverage of Partnering for Cures, a conference bringing together leaders in biotech research to discuss the healthcare business landscape.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.